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Cardiolipins (CL) are mitochondria specific lipids. They play a critical role in ATP synthesis
mediated by oxidative phosphorylation. Abnormal CL distribution is associated with several
disease states. MALDI-MS and MALDI-MS/MS were used to demonstrate in situ analysis and
characterization of CL from tissue sections of organs containing high concentrations of
mitochondria. Once the experimental parameters were established, a survey of CL distribution
in heart, liver, kidney, leg muscle, and testis was undertaken. The major CL specie in the heart
muscle, leg muscle, liver, and kidney is the (18:2)4 CL, while liver and kidney also contain a
minor specie, (18:2)3/(18:1) CL. The major CL specie in testis is the (16:0)4 CL. The CL species
distribution in various organs appeared to be in agreement with prior reports. Overall, proper
matrix selection, tissue section handling, instrument tuning, and the inclusion of cesium ion in
matrix ensured successful in situ MALDI-MS and MALDI-MS/MS analysis of CL. Upon
modification and standardization, this method could be streamlined for rapid pathological
diagnosis with short turnaround time in clinical settings. (J Am Soc Mass Spectrom 2007, 18,
567–577) © 2007 American Society for Mass SpectrometryDiphosphatidylglycerol [1,3-bis(sn-3=-phosphati-dyl)-sn-glycerol; cardiolipin (CL)] belongs to aunique category of lipid. It consists of two
phosphatidic acids linked by a central glycerol. The
CL molecule contains four fatty acid chains, three
glycerols, and two phosphates [1] (Structure 1). The
name “cardiolipin” was given to a lipid from beef
heart first purified by Pangborn in 1942 [2]. CL
substituents were later quantitatively determined by
Macfarlane and colleagues, who subsequently pro-
posed the dimeric structure of this molecule based on
their quantitative analysis [3–5].
The two phosphatidic acids in CL connect to the
central glycerol at the two terminal positions, leaving
the central 2=- hydroxyl group of glycerol unmodified.
Each phosphatidyl moiety of CL contains a distinct
chiral center. The diphosphatidyl arrangement in CL
could give rise to diastereomers and create a unique
chemical environment for each phosphate group. The
central 2=- hydroxyl group is thought to result in
intramolecular hydrogen bonding that alters the pK2 of
CL and to generate the acid-anion in the head group
domain of the molecule. This proposal was supported
by a titration experiment where the pK2 of regular CL
was above 8, but became equivalent to its pK1 (less than
4.0) when the 2=-hydroxyl group was replaced by a
hydrogen [1]. Thus, in spite of the presence of two
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under normal physiological conditions.
In mammalian cells, CL is located in the inner
membrane of mitochondria, and accounts for 10 to 20%
of total mitochondrial lipids [6]. Hence, a high concen-
tration of CL in organ tissue usually indicates a high
amount of mitochondria in such organs whose high
metabolic activities are fueled by large amounts of ATP
generated from mitochondrial oxidative phosphoryla-
tion. In mammals, high amounts of mitochondria can be
found in myocardium, liver, kidney, and skeletal mus-
cle. In prokaryote circle, CL is also associated with
organisms in the eubacteria subkingdom that utilize
oxidative phosphorylation as their energy source.
Much of mitochondrial cytochrome c (Cyt C) is
tightly bound to the CL in its membrane. The Cyt C-CL
complex functions as a peroxidase to scavenge exces-
sive H2O2 generated by oxidative phosphorylation. CL
is also an integral part of Complexes III and IV, which
are an integral part of the electron transport chain
generating electrochemical proton gradients across the
inner mitochondrial membrane. In addition, CL is also
the critical component for the assembly of mitochondria
supercomplex consisting of Complexes III and IV [7].
Several earlier studies of oxidative stress-mediated ap-
optosis demonstrated that mitochondria directly or
indirectly subjected to oxidative stress disrupted the
homeostasis between CL and Cyt C [7–9] and caused
the dissociation of Cyt C-CL complexes. Upon dissoci-
ation, Cyt C is released from the inner mitochondrial
membrane and eventually escapes to the cytoplasm,
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grammed cell death [7].
Many pathological studies have associated the pre-
sentation and progression of pathological conditions
with changes in the fatty acyl moieties of CLs, as seen in
Barth syndrome, an X-linked disease, where a change in
the fatty acid composition of CL is detected [10–14]. The
onset of heart failure in spontaneous hypertensive rats
was also linked to the shifting of fatty acids in myocar-
dial CL from saturated C18 fatty acids to highly unsat-
urated C20 and C22 species [14]. These examples high-
light the biological and pathological importance of CL.
Conventional mass spectrometric analysis of CL in
tissue uses the extraction methods developed by Folch
et al. [15] or Bligh and Dyer [16] as the starting point.
The tissue is homogenized in a chloroform-methanol
mixture, and the homogenate is subjected to various
extraction steps followed by laborious chromatographic
separation and purification before mass spectrometric
analysis [14]. Such sample handling could provide
detailed information on tissue lipid composition. How-
ever, the procedures consume substantial amounts of
time and sample. Further, multistep sample extraction
and processing could potentially cause significant
amounts of sample loss and renders such approach
unsuitable for the analysis of trace amounts of themolecules of interest. In this study, we report an alter-
native approach for direct detection of CLs from tissue
sections without extensive sample processing. Upon
establishing suitable experimental parameters, we sur-
veyed the major CL species from rat organs tissue
sections containing high concentrations of mitochon-
dria, such as heart, liver, kidney, muscle, and testis.
Materials and Methods
Animals
All animal use and handling were approved by the
Animal Care and Use Committee (ACUC) in NIDA-
IRP, NIH. Male Sprague-Dawley rats between 280
and 400 g were used in this study. Rats were eutha-
nized by overdose isoflurane inhalation. Upon cessa-
tion of respiration, the animals were rapidly decapi-
tated and dissected to harvest the liver, heart, kidney,
testes, and a small piece of muscle (m. rectus femo-
ris). The harvested organs were briefly washed in
ice-cold normal saline three times and trimmed into
tissue cubes. The tissue cubes were blot-dried and
rapidly frozen in isopentane prechilled on dry ice,
then wrapped in aluminum foil and stored at below
80 °C until sectioning.
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cryosections with a cryostat (CM 3050S; Leica Microsys-
tems, Nussloch GmbH, Nussloch, Germany). The de-
tailed sectioning and sections handling methodology
was done as previously reported [17]. The sections were
collected onto stainless steel MALDI targets and briefly
thaw-mounted before storage at 20 °C. Small droplets
of matrix solution (0.1 to 0.2 L) were manually depos-
ited onto the tissue regions of interest shortly before
MALDI-MS analyses.
Matrices
Several conventional MALDI matrices were tested; 2,6-
dihydroxyacetophenone (DHA; Fluka, Buchs, Switzer-
land), 2,5-dihydroxy benzoic acid (DHB; Aldrich, Mil-
waukee, WI), 2, 4, 6-trihydroxy acetophenone (THA;
Fluka, Buchs, Switzerland), -cyano-4-hydroxycin-
namic acid (CHCA; Sigma-Aldrich, Gillingham-Dorset,
UK), and sinapinic acid (SA; Aldrich, Milwaukee, WI).
The matrices concentrations were 30 mg/mL in 50%
ethanol. In a separate series of studies, DHA was
prepared in 100 mM cesium iodide solution (Sigma
Chemical Co.; St. Louis, MO) at a 30 mg/mL concen-
tration (see below).
CL Standard
Bovine CL standard containing 87% of (18:2) and 8% of
(18:1) fatty acyl substituents was purchased from
Avanti Polar Lipids (Alabaster, AL; product number:
840012) and reconstituted in chloroform at a concentra-
tion of 10 mg/mL. Equal volumes of CL standard and
matrix solution were premixed before spotting onto the
MALDI target. The MALDI-MS and MALDI-MS/MS
spectra from (18:2)4 CL standard served as calibrants for
the in situ analysis and characterization of CLs.
Mass Spectrometry
The tissue sections were analyzed with a MALDI-TOF/
TOF mass spectrometer (4700 Proteomic Analyzer; Ap-
plied Biosystems Inc., Farmingham, MA) equipped
with a Nd:YAG laser (355 nm) triggered at 200 Hz
repetition rate. The spectra were acquired in reflectron
negative ion mode. The identity of the CL peaks was
confirmed by MALDI-MS/MS. Each MALDI-MS spec-
trum consisted of the sum of 400 consecutive laser
shots, while each MALDI-MS/MS spectrum consisted
of the sum of 1000 consecutive laser shots.
Fragments Assignment
The fragments assignment for the MS/MS studies fol-
lowed the convention of Hsu and Turk [18, 19] with a
slight modification. While the a/b ion represents the
phosphatidic acid of cardiolipin (Structure 2); a  56/b
 56 and a  136/b  136 ions represent the interme-
diate fragments containing the modified central glyc-erol backbone (Structure 3) and the modified phospho-
glycerol backbone (Structure 4), respectively. The
presence of cesium in the fragments, if detected, was
specified.
Results and Discussion
Matrix Suitability
Several conventional MALDI matrices were evaluated
on myocardial tissue sections and on CL standard. The
results indicated that, among the matrices tested, DHA
generated the highest abundance of CL ions from both
tissue and CL standard and the least interference in the
1000 to 2200 m/z range (Figure 1a). When tested on other
organ sections, DHA also gave spectra of equally high
quality. Nonetheless, an empirical observation indi-
cated that DHA sublimates in high vacuum (e.g., 1 
106 torr or lower) within 30 min. Therefore, all the MS
and MS/MS studies were conducted as soon as practi-
cally possible after the target plates were inserted into
the source chamber.
Figure 1a shows a typical MS spectrum of (18:2)4 CL
from a myocardial section of a rat ventricle. The inlet
magnifies the region between m/z 1420 and m/z 1520
that contains the CL molecular ions ([M  H]) at m/z
1447.89, the CL-sodium adduct at m/z 1469.78, and the
CL-potassium adduct at m/z 1485.78. Note that the 1000
to 2200 m/z range is relatively free of other ion species.
We also tested the effect of exogenous alkali metal
ions on detection of CL under the same conditions used
in Figure 1a. Figure 1b shows the spectrum acquired
from the section adjacent to the one used in Figure 1a
that was spotted with DHA containing 100 mM CsI to
generate in situ CL-cesium adducts (CL-Cs). Including
Cs in the matrix decreases the relative abundance of
endogenous sodiated and potassiated CL adducts by
50% (cf. Figure 1a), and results in the CL-Cs adduct at
m/z 1579.77 becoming the base peak. High concentra-
tion of exogenous Cs displaced the sodium and potas-
sium adducted to CL and replaced them with CL-Cs.
The exogenous Cs might also form CL-Cs adducts
with CL molecular ions. The high concentration of Cs
additively increases the in situ molecular abundance of
CL. The exogenous Cs also shifted CL in the form of
CL-Cs to a m/z range that was relatively free of inter-
ference from other ions [20]. Such mass shifting allowed
the use of a wider precursor window, thus increasing
the number of precursor ions for MS/MS studies,
resulting in better MS/MS data. In addition, MS/MS
studies of CL-Cs adduct appear to yield more structural
information than those of the CL molecular ions (see
below).
To confirm the identities of (18:2)4 CL (m/z 1447.89)
and (18:2)4 CL-Cs (m/z 1579.77) from heart muscle, these
molecular ions were selected for MS/MS fragmenta-
tion. The results were compared with the MS/MS
spectra from (18:2)4 CL and (18:2)4 CL-Cs standards.
After a number of MS/MS studies, we observed that it
s a
570 WANG ET AL. J Am Soc Mass Spectrom 2007, 18, 567–577was almost impossible to acquire structurally meaning-
ful spectra from tissue or standards using even the
lowest available collision gas (air) pressure setting (2 
107 torr). All the MS/MS results showed [a-(18:2)]/
[b-(18:2)] ions and the (18:2) fatty acid ions, and other
lowm/z peaks that are signatures of phospholipids (e.g.,
m/z 153.00). Once the collision gas was turned off, the
MS/MS spectra began to reveal more structurally
meaningful fragments such as [a-(18:2)]/[b-(18:2)]
Figure 1. (a) MALDI-MS spectrum of (18:2)4
magnifies them/z region between 1420 and 1520 u
of (18:2)4 CL from rat heart section in the presenc
potassiated CL was significantly decreased by Cions, [a]/[b] ions, [a56]/[b56] ions, [a136]/[b136] ions, [M-(18:2 fatty acid)-H] ion, and
[MCs-(18:2 fatty acid ketene)-2H] ions. To extract
more structural information, MS/MS analysis for the
remainder of the study were carried out without colli-
sion gas. Figure 2a shows the MS/MS spectrum of
(18:2)4 CL molecular ion and Figure 2c the MS/MS
spectrum of (18:2)4 CL-Cs adduct, both from a myocar-
dial section. Figure 2b shows the MS/MS spectrum of
(18:2)4 CL molecular ion from standard and Figure 2d
iolipin (CL) from rat heart section. The inlet
trix: DHA, 30 mg/mL. (b) MALDI-MS spectrum
s ions. The relative abundance of sodiated and
ddition.card
. Ma
e of Cthe MS/MS spectrum of (18:2)4 CL-Cs adduct from
4CL m
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mostly [a]/[b] ions, i.e., (18:2)2 phosphatidic acid
(m/z 695.46), and low abundance of the following frag-
ments: [a56]/[b56] ions (m/z 751.47); [a136]/
[b136] ions (m/z 831.46); [a-(18:2)]/[b-(18:2)] ions
(m/z 415.23) [18, 19]; and (18:2) fatty acid ions (m/z
279.23) (Figure 2a). The results are generally in agree-
ment with MS/MS results of CL standard shown in
Figure 2b. Nonetheless, a minor peak representing
Figure 2. (a) MALDI-MS/MS spectrum of (1
section. (b) MALDI-MS/MS spectrum of (18:2)4[a-(18:2) ketene]/[b-(18:2) ketene]  (m/z 433.37) in Fig-ure 2b was not detected in the heart muscle section. The
difference probably is due to the low abundance of
precursor ions available in the myocardial sections.
The MS/MS of CL-Cs adduct showed a very differ-
ent fragmentation profile (Figure 2c). The [a]/[b] ions
were barely detectable, and the abundance of [a56]/
[b56] ions was low. However, the relative abun-
dance of [a136Cs]/[b136Cs] (m/z 963.37)
was much higher than that of [a]/[b] and [a56]/
CL molecular ion ([MH]) from a rat heart
olecular ion from CL standard.8:2)[b56] ions. In addition, the spectrum also showed
8:2)4
572 WANG ET AL. J Am Soc Mass Spectrom 2007, 18, 567–577moderate abundance of [M-(18:2)-H] and [MCs-
(18:2 ketene)-2H] species (m/z 1167.73 and m/z 1317.58,
respectively). The carboxylate or ketene loss of the CL
precursor was not observed in the MS/MS of myocar-
dial sections, nor were the [aCs]/[bCs] ions
(m/z 827.36) detected. In addition, the relative abun-
dances of [a-(18:2)]/[b-(18:2)] (m/z 415.24) and 18:2
fatty acid molecular ions (m/z 279.28) were dramatically
increased (cf. Figure 2a). The overall result in Figure 2c
Figure 2. Continued. (c) MALDI-MS/MS spect
heart section. (d) MALDI-MS/MS spectrum of (1is largely in agreement with the MS/MS results ofCL-Cs standard in Figure 2d. Table 1 summarizes the
fragments assignment of (18:2)4 CL and (18:2)4 CL-Cs.
Distribution of Major CL Species in Rat Organs
Heart. Heart muscle is a major source of CLs. A
MALDI-MS spectrum (Figure 1a) shows the molecular
ion of (18:2)4 CL (m/z 1447.96), its sodiated (m/z 1470.96)
and its potassiated (m/z 1487.24) adducts from the rat
of (18:2)4 CL-Cs ion ([MCs
2H]) from a rat
CL-Cs ion ([MCs2H]) from CL standard.
rummyocardial sections.
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573J Am Soc Mass Spectrom 2007, 18, 567–577 DIRECT MALDI-MS ANALYSIS OF CARDIOLIPINLiver. Figure 3a shows CL-Cs MS profile from a rat
liver section. The majority of the CL species in liver
appeared to be (18:2)4 CL. However, the deviation of
regular isotopic distribution of CL at m/z 1447.96
cluster and that of CL-Cs cluster at m/z 1579.78
suggested the presence of a minor (18:2)3(18:1) CL
species (Figure 3a and the bottom panel of Figure 3b).
The theoretical isotopic calculation for (18:2)4 CL
indicated that the third isotopic peak at m/z 1449.97
should be 50% as abundant as the C12 peak at m/z
1447.96. However, in Figure 3a the relative abun-
dance of m/z 1449.97 peak was at least 90% that of m/z
1447.97. This isotopic deviation was further empha-
sized by the concentrating effect of Cs seen in the
CL-Cs adduct at m/z 1579.78.
Figure 3b shows a more detailed isotopic compar-
ison of the m/z 1579.78 cluster. The top panel, show-
ing the isotopic distribution of (18:2)4 CL-Cs from rat
heart, agrees with the theoretical calculation. The
bottom panel, from rat liver, shows an increase in
relative abundance of the following isotopic peak at
m/z 1581.78, 1582.78, 1583.77, and 1584.77. The 2 u
increase is most likely due to the difference of a
double-bond in one of the four fatty acid chains. The
MS/MS of liver CL-Cs (m/z 1579.78) in Figure 3c
shows a very similar fragment pattern to that of
(18:2)4 CL-Cs in Figure 2b. Nonetheless, the MS/MS
also shows a m/z 281.23 peak corresponding to (18:1)
fatty acid fragment, which confirms the presence of
(18:1) fatty acid in liver CL. Theoretically, the
[a136Cs]/[b136Cs] fragments and other
high mass fragments should also reflect the presence
of (18:1) fatty acid in liver CL. However, the spectrum
did not show such a variation. This discrepancy could
be due to low precursor ion abundance in spite of the
efforts to increase the precursor ion counts. Also, the
lack of evidence for the presence of (18:1) fatty acid
chain in the [M-fatty acid-H] and [MCs-fatty acid
ketene-2H] fragments could be due to the stereospe-
cific numbering (sn) position of the (18:1) fatty acid on
CL [18, 19, 21]. According to an earlier study, the
(18:1) fatty acid chain of rat liver CL was located in
sn-2 (or sn-2=) position [13]. In addition, according to
earlier studies by Hsu and Turk [18, 19], the MS/MS
of sodiated CL [MNa-2H] preferentially dissoci-
ated the fatty acid at sn-2 (or sn-2=) position.
Kidney. The MS profile of kidney CL is identical to
that of liver. The major CL specie is the (18:2)4 CL,
and the minor CL specie is the (18:2)3/(18:1) CL.
Their structure was confirmed by MS/MS of CL-Cs
adducts.
Leg muscle. The MS profile of CL in leg muscle ap-
peared identical to that of heart muscle where only
(18:2)4 CL was detected. The identity was also con-
firmed by MS/MS of the CL-Cs adduct.Ta M
o
M
o
C
o
Figure 3. (a) MALDI-MS spectrum of (18:2)4 and (18:2)3/(18:1) CL from a rat liver section in the
presence of Cs ion. (b) Isotopic distribution of CL-Cs from a rat heart section (top panel) and a rat
liver section (bottom panel). Note the increase in abundance of m/z 1581.78 peak in the bottom panel.
(c) MALDI-MS/MS spectrum of (18:2)4  (18:2)3/(18:1) CL-Cs from a rat liver section.
575J Am Soc Mass Spectrom 2007, 18, 567–577 DIRECT MALDI-MS ANALYSIS OF CARDIOLIPINTestis. Figure 4a shows the MS profile of CL from
testis. Unlike the CL profiles in other organs, the major
CL specie in testis is the (16:0)4 CL atm/z 1352.05, whose
cesium adduct is at m/z 1483.94. Figure 4b shows the
MS/MS spectrum of (16:0) CL-Cs. Table 2 lists the
fragments of (16:0)4 CL and (16:0)4 CL-Cs. The m/z
Figure 4. (a) MALDI-MS spectrum of (16:0)4
containing 100 mM CsCl. (b) MALDI-MS/MS sp
testis section.1245.75 peak represents the (16:0)4 CL-Cs losing onefatty acid as a ketene, while the m/z 1095.81 peak
represents the loss of a fatty acid and Cs from CL-Cs
adduct. The m/z 915.39 peak represents the
[a136Cs]/[b136Cs] fragment. The relative
abundance of [a56]/[b56] ions was again quite
low, and the [a]/[b] ions were essentially undetect-
Cs spectrum from a rat testis section, matrix
m of (16:0)4 CL-Cs ([MCs
2H]) from a rat
CL-
ectruable. A m/z 391.26 peak, representing [a-(16:0)]/[b-(16:
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576 WANG ET AL. J Am Soc Mass Spectrom 2007, 18, 567–5770)] fragment, and the (16:0) fatty acid ion at m/z 255.32
were also detected. Overall, the MS/MS profile of
(16:0)4 CL-Cs is very similar to that of (18:2) CL-Cs seen
in Figure 2c.
In this study, we demonstrated that proper selection
of MALDI matrix and sample preparation are critical
for the success of direct analysis of lipids in tissue
sections. In our experience, DHA is the most suitable
matrix for such applications. When the relative abun-
dance of the molecules of interest is low, matrix selec-
tion and instrument tuning will influence significantly
the outcome of the studies. In spite of being the pre-
ferred matrix for lipid detection, the sublimation of
DHA in high vacuum within 30 to 45 min creates a
minor inconvenience that can be overcome by respot-
ting the matrix solution onto the regions defined by the
prior matrix deposition.
It is interesting to note that MS/MS of CL molecular
ion generated a fatty acid loss as ketene, which was
presented as [a-(fatty acid ketene)/b-(fatty acid ketene)]
ion (Figure 2b), while it is presented as [MCs-(fatty
acid ketene)-2H] ion when CL-Cs was the precursor
(Figure 2d). This phenomenon was confirmed by MS/MS
of CL-Na as the precursor (spectrum not shown). The
alkali metal ion increases the basicity of gaseous CL ion
and lead to a preferential sn-2 fatty acid loss as a ketene, as
previously depicted [18, 19, 21, 22]. The exogenous Cs
seemed to neutralize the negative charge on one of the
phosphate groups of CL, preventing its access to the
exchangeable hydrogen on the central glycerol, hence
driving the fragmentation path towards a preferential
formation of [a136Cs]/[b136Cs] ions. In the
absence of Cs, the fragmentation path was driven to-
wards the formation of [a]/[b] ions that derived from
[a56]/[b56] fragment ions [19, 22].
Our study showed that the predominant CL spe-
cies in rat heart, leg muscle, liver, and kidney is the
(18:2)4 CL; we also detected a minor species (18:2)3/
(18:1) CL in liver and kidney. The relative abundance
of liver (18:2)3/(18:1) CL, as indicated by the relative
abundance of (18:1) fatty acid (m/z 281.23), was about
25 to 30% of that of (18:2) fatty acid (m/z 279.23).
These results appear largely in agreement with the
study by Schlame et al. on CL species distribution in
mammalian organs [13].
The CL in testes, however, is dominated by (16:0)4
CL. Such distribution difference may be the result of
evolutionary adaptation of spermatozoa to their envi-
ronment. Clinical studies have associated sterility with
oxidative stress-mediated DNA damage in spermato-
zoa [23–25]. As was previously mentioned, mitochon-
drial CL would dissociate from the Cyt C-CL complex
upon oxidation, and subsequently trigger a cascade of
apoptotic events [7–9]. Since lipid peroxidation usually
occurs at the unsaturated bonds of fatty acids, elimina-
tion of unsaturated fatty acids in testicular CL could be
regarded as the result of an evolutionary-derived pro-
tective mechanism to increase the fertility of spermato-
zoa by reducing their chance of undergoing lipid per-Ta M
o
[M M
o
[M Co
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specialized functional environment [23–25].
One of the advantages in MALDI-MS detection of
CLs over ESI-MS technique is that, unlike in ESI where
multiply charged ions are seen, the entire population of
CL species in MALDI-MS are detected as singly
charged ion species. Analysis of singly charged CL
species allows a clearer separation of their isotopic
peaks and might offer more accurate relative abun-
dance information of molecular species that are sepa-
rated by only 2 or 4 u [14]. The detection of mixed CL
species in liver by its isotopic pattern and the subse-
quent MS/MS confirmation of its (18:1) fatty acid
relative abundance further signify the advantages of
MALDI-MS in such applications.
Although MALDI-MS has the advantage of generat-
ing singly charged molecular ions over ESI-MS, the
latter will always be the technique of choice for quan-
titative analysis [26]. In addition, due to instrumental
limitation, we could only perform MS/MS on the
precursor ions. Further identification of the fragment
ions generated by MS/MS will require an ion trap mass
spectrometer for conducting MSn fragmentation.
In summary, with proper matrix selection and in-
strument setting, the in situ analysis of CL from organ
sections containing high concentrations of mitochon-
dria is achievable. Further modification and refinement
of the current method could permit its adaptation for
the fast screening of changes in lipid biomarkers asso-
ciated with mitochondria related diseases in biopsy
samples, and would offer a rapid turnaround time with
little sample consumption.
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